Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
13 pending office actions • 9 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
The University of Delaware currently manages 13 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 9 distinct art units, indicating a range of subject matter within this specific field.
HINA F AYUB is the busiest examiner for the university, though this examiner is responsible for 1 pending office action. This distribution shows that no single examiner holds a concentrated portion of the portfolio. The presence of 13 distinct examiners suggests a prosecution landscape where each matter is handled by a different individual, matching the total count of pending actions.
Practitioners should note the spread across 9 distinct art units. This variety requires familiarity with multiple examination groups even within the Biotechnology & Pharmaceuticals sector. The matching counts of 13 pending office actions and 13 distinct examiners further highlights the lack of examiner concentration for this entity. This ensures that no single examiner's habits dominate the university's current experience.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 5 (38%) |
| §112 only | 2 (15%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AYUB, HINA F | 1 | 84.9% | +17.4% |
| WEARE, MEREDITH H | 1 | 50.4% | +31.7% |
| GRAHAM, CHANTEL LORAN | 1 | 71.7% | +11.5% |
| RAGHU, GANAPATHIRAM | 1 | 73.6% | +26.4% |
| LEONARD, MICHAEL L | 1 | 63.7% | +8.3% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| REDDIG, PETER J | 1 | 57.9% | +40.2% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 66.7% | +0.0% |
| WEBB, WALTER E | 1 | 46.3% | +18.8% |
| GRAHAM, ANDREW D | 1 | 59.7% | +22.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350357 | FOAM VACCINATION OF AVIANS | CORNELIUS, CLAIRE ADRIENNE | 31d overdue |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 28d |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | — |
| 17764593 | INDIRECT THREE-DIMENSIONAL CO-CULTURE OF DORMANT TUMOR CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — |
| 17641254 | EX VIVO LYMPH NODE AND USES THEREOF | HUMPHRIES, NICHOLAS ADAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274118 | PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY | REDDIG, PETER J | 12d |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 28d |
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | — |
| 18874111 | DEVICES, METHODS, AND SYSTEMS FOR COLLECTING AQUATIC FIELD METABOLIC RATE DATA | WEARE, MEREDITH H | — |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | GRAHAM, CHANTEL LORAN | — |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | — |
| 18516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | SPENCE, JENNIFER SUZANNE | — |
| 18032094 | CELLULAR MEMBRANE VESICLES AND USES THEREOF | WEBB, WALTER E | — |
| Art Unit | Apps |
|---|---|
| 1763 | 1 |
| 1633 | 1 |
| 1646 | 1 |
| 1672 | 1 |
| 1612 | 1 |
| 1742 | 1 |
| 1632 | 1 |
| 1631 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19101051 | SYSTEM AND APPARATUS FOR MEASURING SCATTERED LIGHT SIGNALS FROM PRESSURIZED SOLUTIONS AND METHOD OF ASSEMBLY | AYUB, HINA F | — | §112 | Non-Final OA | — | Pending | Feb 04, 2025 |
| 18874111 | DEVICES, METHODS, AND SYSTEMS FOR COLLECTING AQUATIC FIELD METABOLIC RATE DATA | WEARE, MEREDITH H | — | §103 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | GRAHAM, CHANTEL LORAN | — | §103 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18847362 | L-THREONINE TRANSALDOLASES AND USES THEREOF | RAGHU, GANAPATHIRAM | — | §103§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18540190 | LIGNIN-DERIVED AND PERFORMANCE-ENHANCED NON-ISOCYANATE POLYURETHANE THERMOSETS | LEONARD, MICHAEL L | 1763 | §103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | SPENCE, JENNIFER SUZANNE | 1633 | §102§103DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18274118 | PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY | REDDIG, PETER J | 1646 | §103Other | Non-Final OA | 12d | Pending | Jul 25, 2023 |
| 18350357 | FOAM VACCINATION OF AVIANS | CORNELIUS, CLAIRE ADRIENNE | 1672 | §102§103 | Non-Final OA | 31d overdue | Pending | Jul 11, 2023 |
| 18032094 | CELLULAR MEMBRANE VESICLES AND USES THEREOF | WEBB, WALTER E | 1612 | §103 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18131669 | POSITIVE DISPLACEMENT PUMP MATERIAL DELIVERY SYSTEM FOR ADDITIVE MANUFACTURE | GRAHAM, ANDREW D | 1742 | §102§103 | Non-Final OA | 28d | Pending | Apr 06, 2023 |
| 17764593 | INDIRECT THREE-DIMENSIONAL CO-CULTURE OF DORMANT TUMOR CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | 1632 | §102§103 | Non-Final OA | — | Pending | Mar 29, 2022 |
| 17641254 | EX VIVO LYMPH NODE AND USES THEREOF | HUMPHRIES, NICHOLAS ADAM | 1631 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 08, 2022 |
| 16624422 | CAPTURE OF CIRCULATING TUMOR CELLS USING CARBON NANOTUBE SPONGES | BENAVIDES, JENNIFER ANN | 1675 | §112 | Final Rejection | 70d | Pending | Dec 19, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial